These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 30539486)
1. Production of Stabilized Antibody Fragments in the E. coli Bacterial Cytoplasm and in Transiently Transfected Mammalian Cells. Birnboim-Perach R; Grinberg Y; Vaks L; Nahary L; Benhar I Methods Mol Biol; 2019; 1904():455-480. PubMed ID: 30539486 [TBL] [Abstract][Full Text] [Related]
2. Production of stabilized scFv antibody fragments in the E. coli bacterial cytoplasm. Vaks L; Benhar I Methods Mol Biol; 2014; 1060():171-84. PubMed ID: 24037842 [TBL] [Abstract][Full Text] [Related]
3. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. Bach H; Mazor Y; Shaky S; Shoham-Lev A; Berdichevsky Y; Gutnick DL; Benhar I J Mol Biol; 2001 Sep; 312(1):79-93. PubMed ID: 11545587 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process. Sarker A; Rathore AS; Gupta RD Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336 [TBL] [Abstract][Full Text] [Related]
5. Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in Byun KT; Kim B; Cho J; Lee I; Lee MG; Park D; Kang TB; Won HS; Kim CG Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892190 [TBL] [Abstract][Full Text] [Related]
6. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli. Bu D; Zhou Y; Tang J; Jing F; Zhang W Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of in vitro refolding vs cold shock expression: Production of a low yielding single chain variable fragment. Vermeulen JG; Burt F; van Heerden E; Cason E; Meiring M Protein Expr Purif; 2018 Nov; 151():62-71. PubMed ID: 29894804 [TBL] [Abstract][Full Text] [Related]
8. Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli. Gaciarz A; Veijola J; Uchida Y; Saaranen MJ; Wang C; Hörkkö S; Ruddock LW Microb Cell Fact; 2016 Jan; 15():22. PubMed ID: 26809624 [TBL] [Abstract][Full Text] [Related]
9. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain. Hayhurst A Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163 [TBL] [Abstract][Full Text] [Related]
10. Cloning, expression and efficient refolding of carbohydrate-peptide mimicry recognizing single chain antibody 2D10. Tapryal S; Krishnan L; Batra JK; Kaur KJ; Salunke DM Protein Expr Purif; 2010 Aug; 72(2):162-8. PubMed ID: 20363331 [TBL] [Abstract][Full Text] [Related]
11. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system. Moricoli D; Muller WA; Carbonella DC; Balducci MC; Dominici S; Watson R; Fiori V; Weber E; Cianfriglia M; Scotlandi K; Magnani M J Immunol Methods; 2014 Jun; 408():35-45. PubMed ID: 24798881 [TBL] [Abstract][Full Text] [Related]
12. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli. Babaei A; Zarkesh-Esfahani SH; Gharagozloo M J Microbiol Biotechnol; 2011 May; 21(5):529-35. PubMed ID: 21617352 [TBL] [Abstract][Full Text] [Related]
13. Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties. Vendel MC; Favis M; Snyder WB; Huang F; Capili AD; Dong J; Glaser SM; Miller BR; Demarest SJ Arch Biochem Biophys; 2012 Oct; 526(2):188-93. PubMed ID: 22230329 [TBL] [Abstract][Full Text] [Related]
14. Preparation of single-chain Fv antibodies in the cytoplasm of Escherichia coli by simplified and systematic chaperone optimization. Liu C; Kobashigawa Y; Yamauchi S; Toyota Y; Teramoto M; Ikeguchi Y; Fukuda N; Sato T; Sato Y; Kimura H; Morioka H J Biochem; 2019 Dec; 166(6):455-462. PubMed ID: 31755921 [TBL] [Abstract][Full Text] [Related]
15. Autoinduction as Means for Optimization of the Heterologous Expression of Recombinant Single-Chain Fv (scFv) Antibodies. Nikolova G; Georgieva Y; Atanasova A; Radulova G; Kapogianni A; Tsacheva I Mol Biotechnol; 2021 Nov; 63(11):1049-1056. PubMed ID: 34215946 [TBL] [Abstract][Full Text] [Related]
16. Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies. Gupta V; Sudhakaran IP; Islam Z; Vaikath NN; Hmila I; Lukacsovich T; Kolatkar PR; El-Agnaf OMA PLoS One; 2020; 15(11):e0241773. PubMed ID: 33156828 [TBL] [Abstract][Full Text] [Related]
17. Redesigning of anti-c-Met single chain Fv antibody for the cytoplasmic folding and its structural analysis. Edwardraja S; Neelamegam R; Ramadoss V; Venkatesan S; Lee SG Biotechnol Bioeng; 2010 Jun; 106(3):367-75. PubMed ID: 20178123 [TBL] [Abstract][Full Text] [Related]
18. A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies. Sun W; Xie J; Lin H; Mi S; Li Z; Hua F; Hu Z Protein Expr Purif; 2012 May; 83(1):21-9. PubMed ID: 22387083 [TBL] [Abstract][Full Text] [Related]
19. Effects of variable domain orientation on anti-HER2 single-chain variable fragment antibody expressed in the Escherichia coli cytoplasm. Koçer İ; Cox EC; DeLisa MP; Çelik E Biotechnol Prog; 2021 Mar; 37(2):e3102. PubMed ID: 33190426 [TBL] [Abstract][Full Text] [Related]
20. Generation of scFv specific to human VEGFR-3 from the neutralizing mAb BDD073. Chen H; Wang C; Gao Y; Gao J; Zhou X; Cai Z; Sun Q Protein Eng Des Sel; 2015 Jan; 28(1):19-22. PubMed ID: 25428897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]